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Calculation of relative absorbance values
For the CdSO 4 treatment conditions, the relative absorbance values were calculated using the ratio of the absorbance values at 490 nm for the treatment condition subtracted by the no cell background values (control 1) to the absorbance value for the CdSO 4 vehicle control cells (control 7) subtracted by the no cell background values (control 1). The following are the equations used for several of the treatment conditions ( Fig. 2 at https://doi. org/10.14573/altex.1605021 shows the plate layout). relative absorbance (0) = (median (B3-B5) -median (B2-G2)) / (median(B3-B5) -median (B2-G2)) = 1 relative absorbance (1) = (median (C3-C5) -median (B2-G2)) / (median(B3-B5) -median (B2-G2)) relative absorbance (10) = (median (D3-D5) -median (B2-G2)) / (median(B3-B5) -median (B2-G2)) relative absorbance (25) = (median (E3-E5) -median (B2-G2)) / (median(B3-B5) -median (B2-G2)) For the NP treatment conditions, the relative absorbance values were calculated using the ratio of the absorbance values at 490 nm for the treatment conditions subtracted by background (no cells but with NP addition at the treatment concentration) to the absorbance value for the NP vehicle control cells (control 8) subtracted by the no cell background. The following are the equations used for several of the treatment conditions ( Fig. 2 at https://doi.org/10.14573/altex.1605021 shows the plate layout). relative absorbance (0) = (median (B8-B10) -value (B11)) / (median(B8-B10) -value (B11)) = 1 relative absorbance (1) = (median (C8-C10) -value (C11)) / (median(B8-B10) -value (B11)) relative absorbance (10) = (median (D8-D10) -value (D11)) / (median(B8-B10) -value (B11)) relative absorbance (25) = (median (E8-E10) -value (E11)) / (median(B8-B10) -value (B11))
In vitro sedimentation, diffusion and dosimetry modeling
The main transport processes of particles in suspension are diffusion (Stokes-Einstein Equation) and gravitational settling (Stokes' Law), both of which directly depend on particle size and density. Diffusion is inversely related to particle diameter while sedimentation is driven by particle diameter to the power of two (Teeguarden et al., 2007) . Thus, the agglomeration of primary particles is a process that affects particle size, shape and density and therefore directly affects particle transport (Hinderliter et al., 2010; DeLoid et al., 2014) . Typically, an agglomerate possesses interparticle pore space, i.e., entrapped media between its constituent primary particles, because the particles are not efficiently packed, which is why they have been modeled as a fractal structure (Sterling et al., 2005; Hinderliter et al., 2010) . Interparticle pore space affects both agglomerate porosity and reduces the resulting agglomerate density. The two main sources of interparticle pore space in agglomerates are packing effects and the fractal nature of a particle, the former of which is described by the packing factor (PF) and the latter of which by the fractal dimension (FD), both of which are not well known and not experimentally measurable (Cohen et al., 2012) . The packing factor (PF) describes how particles are packed into agglomerates and depends on the monomer shape. The value for the PF is between 0 and 1 (absence of porosity, efficiently packed), and the empiric default is 0.637 for randomly packed spherical monomers. The fractal dimension (FD) depends on how the agglomerate forms through flocculation and takes on values between 1 (rod shaped) and 3 (perfect sphere, porosity = 0), and its empiric default value is 2.3 (Cohen et al., 2012; Hinderliter et al., 2010) . The ISDD model based on agglomerate diameter (i.e., using the Sterling equation) was used to estimate the effective NP dose at the plate surface in the presence S2 particle transport process. This observation is consistent with previous simulations of carboxylated polystyrene particles of similar sizes (Hinderliter et al., 2010) . The fraction of administered dose delivered in the serum-free treatment at 24 h and serum treatments at 48 h was 0.1846 and 0.0662, respectively (Tab. S6); uncertainty values calculated based on changing the z-average diameter by 10% are provided in Table S6 . It must be noted, however, that the ISDD model generally overestimates the deposited fraction of administered dose. In the case of carboxylated polystyrene the ratio of simulated to measured rates of transport has been shown to vary from 0.37 up to three-fold, for NP diameters 100 nm to 1100 nm (Hinderliter et al., 2010) . This is likely due to the underlying model assumptions, most importantly concerning the bottom boundary condition assuming a 100% sticky well bottom (i.e., NPs that reach the bottom are immediately internalized by cells and no longer affect particokinetics) and other limitations recently described by DeLoid et al. (2015) .
Dosimetrically adjusted EC 50 values reported in delivered dose metrics are provided in Table S7 , and have important implications for the interpretation of the potency of NH 2 -PS NPs as well as the biological responses. The adjusted dose metrics are similar between the two exposure conditions, suggesting that the differences implied by the conventional administered dose metric are likely due to differential particokinetics in serum-containing and serum-free conditions rather than biological activity of particles/ cell sensitivity in serum-containing and serum-free conditions. These findings highlight the importance of integrating the bioavailability of NPs into in vitro nanotoxicity testing. and absence of serum in the culture media. It uses the agglomerate diameter and FD to calculate agglomerate density, porosity and transport. All of the input parameters used to model the NH 2 -PS NPs in the MTS assay are listed in Table S8 .
The simulation yields four output values: 1) the fraction of administered dose deposited and the corresponding 2) total number, 3) total surface area (of a sphere) [cm 2 ] and lastly 4) total mass [µg] in terms of primary NPs deposited. These values were then normalized to the total surface area of the well bottom corresponding to the 96-well plates (0.34 cm 2 ) to obtain the mass dose [µg/cm 2 ], number dose [#/cm 2 ] and surface area dose [cm 2 NPs/cm 2 well bottom], which were then used to interpret the obtained dose-response relationships and EC 50 values.
B Supplementary results and discussion
In vitro sedimentation, diffusion and dosimetry modeling ISDD simulations suggest that the delivered dose at the bottom of the exposure vessel is time and treatment dependent (Tab. S6). The administered NP concentration did not affect the fraction of the delivered dose, which is in line with the underlying model assumptions that do not account for dynamic NP interactions and agglomeration during the simulated exposure period. The fraction of administered dose was highest for smallest particles and decreased with increasing diameters (Tab. S6), which may be explained by the reduced density of large agglomerates through media entrapment within, approximating that of the media itself, and also suggests that diffusion was the dominant Tab. S1: Reagent supply 
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Tab. S5: EC50 values for NH2-PS NP in A549-A and A549-B cells in the presence of serum and in serum-free conditions
Mean (mg/l) 1 Median (mg/l) 95% CI (lower limit, upper limit) (µg/l) 
A549-A cells -serum free
Fig. S1: A549 Cell Line Authentication by Short Tandem Repeat DNA sequences for cell lines A549-A and A549-B
Both cell lines were authenticated and compared by their STR genotypes (PowerPlex Fusion, Promega, Madison, WI).
The results indicate that the A549-B cells have the expected STR markers as described by the vendor (ATCC, Manassas, VA). Interestingly, the A549-A cells have 23 identical STR markers with the exception of a single drop out of the 12 allele at the CSF1PO locus (VIC Dye Channel, Fig. S3d ). This locus is located on chromosome 5 and suggests that A549-A cell line may have a mutation in the primer binding site, which may have caused failure in the amplification of the 12 allele.
Fig. S2: Scanning electron micrograph and primary particle size histogram for the NH2-PS NP
Reprinted with permission of The Royal Society of Chemistry (Hanna et al., 2016) .
